- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£189.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£122.40
7D
5.9%
1Y
2.3%
Chugai Pharmaceutical
Market Cap: JP¥11.5t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥6,986.00
7D
1.8%
1Y
12.5%
Orion Oyj
Market Cap: €11.2b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€79.25
7D
1.5%
1Y
14.3%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥52.4b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥112.19
7D
-6.5%
1Y
19.6%
Xiamen Amoytop Biotech
Market Cap: CN¥25.3b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥59.47
7D
1.5%
1Y
-30.1%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.1b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€59.80
7D
3.8%
1Y
2.6%
PharmaResearch
Market Cap: ₩4.2t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩416,000.00
7D
4.5%
1Y
-40.1%